Recent breakthroughs in blood-based biomarkers of Alzheimer disease: opportunities and challenges in older adults.

Recent advances in Blood-Based Biomarkers (BBMs) are transforming the diagnostic landscape of Alzheimer Disease (AD), with plasma p-tau217 emerging as a highly accurate and scalable diagnostic marker of AD pathology. Across multiple analytical platforms, plasma p-tau217 has demonstrated consistently...

Descripción completa

Detalles Bibliográficos
Publicado en:	Age & Ageing Vol. 55; no. 7; pp. 1 - 6
Autores principales:	Dyer, Adam H, Dolphin, Helena, Roitto, Hanna-Maria, O'Connor, Antoinette, Welsh, Tomas J, Kennelly, Sean P
Formato:	Artículo
Publicado:	Oxford University Press / USA Jul2026
Materias:	Alzheimer's disease diagnosis Amyloidosis diagnosis Medical protocols Tau proteins Alzheimer's disease Mild cognitive impairment Frail elderly Diagnostic errors Polypharmacy Chronic kidney failure Geriatric assessment Conceptual structures Evidence-based medicine Dementia Biological assay Biomarkers Comorbidity Integrated health care delivery Sensitivity & specificity (Statistics)
Acceso en línea:	Ver este registro en EBSCOhost